The largest database of trusted experimental protocols
Sourced in United States, China, Japan, Germany, France, United Kingdom, Canada, Spain, India, Belgium

HepG2 is a human liver cell line derived from the liver tissue of a 15-year-old Caucasian male with a well-differentiated hepatocellular carcinoma. It is a widely used in vitro model for the study of liver cell biology and function.

Automatically generated - may contain errors

2 339 protocols using hepg2

1

Cell Culture Protocols for Common Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T (American Type Culture Collection (ATCC) CRL-3216), HeLa (ATCC CCL-2), MEFs (ATCC CRL-2991), HepG2 (ATCC HB-8065), and A549 (ATCC CCL-185) cells were purchased from ATCC and cultured and passaged in Dulbecco’s modified Eagle’s medium (DMEM) plus GlutaMAX (ThermoFisher Scientific) for HEK293T/HeLa/MEFs, minimum essential medium (MEM; Corning) for HepG2, and F-12K (ATCC) for A549, each supplemented with 10% (v/v) fetal bovine serum (FBS; Gibco, qualified). All cell types were incubated, maintained, and cultured at 37 °C with 5% CO2. Cell lines were authenticated by their respective suppliers and tested negative for mycoplasma.
+ Open protocol
+ Expand
2

Cell Line Acquisition and Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
HepG2, Hep3B and SNU182 were obtained from the American Type Culture Collection (Manassas, VA). QSG-7701, QGY-7703, BEL7402 and PLC8024 were obtained from the Institute of Virology, Chinese Academy of Medical Sciences, Beijing, China. MiHA was provided by Dr. J.R. Chowdhury, Albert Einstein College of Medicine, New York [20 (link)]. Huh7 was provided by Dr. H. Nakabayashi, Hokkaido University School of Medicine, Japan [21 (link)]. All cell lines, except HepG2, were cultured in DMEM medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (Invitrogen), penicillin (500 U/ml) and streptomycin (500 μg/ml) in a 5% CO2 incubator at 37ΰC. HepG2 was maintained in EMEM medium (ATCC, Manassas, VA) supplemented with same concentration of FBS and penicillin and streptomycin. All cell lines used in this study were regularly authenticated by morphological observation and tested for absence of Mycoplasma contamination using MycoAlert kit (Lonza, Switzerland).
+ Open protocol
+ Expand
3

In Vivo Evaluation of ALKBH5 Knockdown in Liver Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human HCC cell lines L02, HepG2, MHCC97H, HepG2.2.15 were from ATCC (Manassas, USA). The primary human hepatocytes (PHH) were purchased from the iCELL company (Shanghai, China) and the HepG2-NTCP cells were previously constructed by our institute. The stable ALKBH5-knockdown (KD) cell lines of HepG2.2.15 were generated by lentivirus infection with puromycin selection according to the manufacturer’s protocol (Santa Cruz). Male athymic BALB/c nude mice (4 weeks old) were used for tumor formation assay. The animal experiments were approved according to the guidelines of the Animal Care and Use Committee of the First Affiliated Hospital of Kunming Medical University (IACUC Issue No: kmmu2019370), and the study was carried out in compliance with the ARRIVE guidelines. HepG2.2.15 cells with ALKBH5-KD or control were prepared in PBS and injected subcutaneously with 1 × 107 cells of the nude mice. After 3 weeks, tumors were excised to measure weight.
+ Open protocol
+ Expand
4

Culturing Immortalized Liver Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco’s modified Eagle’s medium (DMEM) was purchased from Hyclone (Logan, UT, USA). Fetal Bovine Serum (FBS) was obtained from Gibco (Detroit, MI, USA). Penicillin-streptomycin (PS) and 0.25% Trypsin-EDTA were purchased from Solarbio (Beijing, China). Immortalized normal liver cell line LO2 and human HCC cell lines HepG2 and HepG2.2.15 (ATCC, Manassas, VA, USA) were used for the investigation. All the cells were maintained in DMEM containing 10% FBS and 1% PS. A 37°C incubator with 5% carbon dioxide (CO2) was used for cell culture.
+ Open protocol
+ Expand
5

Cell Culture Protocol for HepG2 and NIH 3T3

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two different cell lines, HepG2 and NIH 3T3 (both from ATCC, Manassas, VA, United States) were cultured to ∼90% confluence after 21–25 h of growth under standard conditions (5% CO2/95% O2 at 37°C): Seeding densities for HepG2 and NIH 3T3 were 6.97 × 104 and 6.67 × 104 cells/cm2, respectively. HepG2 cells were cultured in Eagle’s Minimal Essential Medium supplemented with 10% (v/v) fetal bovine serum (FBS), 1% (v/v) of non-essential amino acid (NEAA) mixture, and 1 mM sodium pyruvate. NIH 3T3 cells were cultured in Dulbecco’s Modified Eagle’s Medium supplemented with 10% (v/v) newborn calf serum (NCS) (Gibco, Paisley, United Kingdom). All culture media were supplemented with penicillin (100 IU/mL), streptomycin (100 μg/mL), and L-glutamine (2 mM). All cell media and supplements were obtained from Sigma-Aldrich (St. Louis, MO, United States), except serum (Gibco, Paisley, United Kingdom). The 96-well plates were from Corning Costar (Sigma-Aldrich, Brøndby, Denmark).
+ Open protocol
+ Expand
6

Culturing Hepatocellular Carcinoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The normal liver cells (HepaRG) and HCC cell lines (SMMC-7721, HepG2.2.15, HepG2 and Huh7) were purchased from ATCC(Manassas, VA, USA). HCC cells were cultured in a RPMI 1640 medium containing 10% fetal bovine serum (FBS) and HepaRG cells in keratinocyte-SFM (Thermo Fisher, Jijie Technology, Wuhan, China), together with 100 U/mL penicillin(Baomanbio, Pudong, Shanghai, China) and 100 μg/mL streptomycin(Yita Bio, Pinggu, Haidian, Biejing, China) with 5% CO2 at 37°C.
+ Open protocol
+ Expand
7

Culturing Immortalized Liver Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The immortalized normal liver epithelial cells, THLE-3, were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA) and were cultured under the conditions stated by the manufacturer. The HCC cell lines: HepG2, Hep3B, MHCC97H, MHCC97L, BEL-7402, Huh7, SMMC-7721, PLC/PRF/5, and QGY-7703 were kindly donated by Prof. Qian Wang (Sun Yat-Sen University, Guangzhou, China), which HepG2, Hep3B and PLC/PRF/5 were purchased from ATCC, and MHCC97H, MHCC97L, BEL-7402, Huh7, SMMC-7721 and QGY-7703 were purchased from Shanghai Yansheng industrial Co. (Shanghai, China). The HCC cells were grown in Dulbecco’s modified Eagle’s medium (DMEM, Gibco-BRL, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS, Gibco-BRL) supplemented with 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco-BRL), at 37°C in a 5% CO2 atmosphere in a humidified incubator.
+ Open protocol
+ Expand
8

Cell Culture Protocols for Multiple Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human hepatoma cell lines HepG2 and C3A, a subclone of HepG2 (ATCC HB-8065), were purchased from the ATCC and cultured in Dulbecco’s modified Eagle medium (DMEM)/F12 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Invitrogen). Lung cancer cell line A549 was obtained from the ATCC and maintained in DMEM supplemented with 10% FBS. GP2-293 and Lenti-X 293T cell lines were purchased from Clontech and cultured in DMEM supplemented with 10% FBS and 1 mM sodium pyruvate (Invitrogen). Flp-In TREx 293 cells were purchased from Invitrogen and maintained in DMEM supplemented with 10% FBS, 10 μg/ml blasticidin (Invitrogen), and 100 μg/ml zeocin (Invivogen) (72 (link)). Flp-In TREx 293-derived cell lines expressing LY6E, GILT, ADAP2, or IFITM3 were cultured in DMEM supplemented with 10% FBS, 5 μg/ml blasticidin, and 250 μg/ml hygromycin.
+ Open protocol
+ Expand
9

Macrophage Polarization with Botanical Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
HepG2 and THP-1 cell lines (American Type Culture Collection, ATCC, Manassas, VA, USA) were authenticated and stored in accordance with the instructions provided by the supplier. HepG2 and THP-1 cells were cultured in Eagle’s Minimum Essential Medium (ATCC) and Roswell Park Memorial Institute (RPMI)-1640 medium (Lonza, Verviers, Belgium), respectively, in the presence of 10% fetal bovine serum (FBS, Life Technologies, Monza, Italy) and 1% penicillin-streptomycin in a humidified 5% CO2 atmosphere at 37 °C. THP-1 monocytes were plated and differentiated into macrophages (M0) with phorbol 12-myristate 12-acetatate (PMA) 100 nM for 24 h and then within a medium without PMA for 1 day, as described by Gionfriddo et al. [27 (link)]. M0 macrophages were exposed to 0.1 and 0.2 mg/mL of BL and BS, dissolved in distilled water and dimethylsulfoxide (DMSO), respectively, prior to treatment for 24 h with Lipopolysaccharide (LPS) 10 ng/mL, which was able to polarize M0 into the inflammatory M1 macrophages.
+ Open protocol
+ Expand
10

Immunotherapeutic Targeting of Liver and Breast Cancers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human liver cancer cell lines HepG2, HepG2.2.15, SMMC‐7721, Huh‐7, and BEL7402; murine liver cancer cell line H22; and human breast cancer cell line MDA‐MB‐231 were obtained from the ATCC. The cells were cultured in DMEM/RPMI‐1640 medium, with 10% fetal bovine serum and 1% penicillin/streptomycin in culture conditions of 5% CO2 in air at 37°C. CPI‐203 was purchased from MedChemExpress (MCE). Human antibodies specific for BRD4, GAPDH, and β‐actin were purchased from Cell Signaling Technology. Human anti‐PD‐L1 antibody was purchased from Abcam. Mouse antibody specific for PD‐L1 as well as recombinant human IFN‐γ were purchased from Proteintech. Mouse anti‐CD3–FITC, anti‐CD4–APC, anti‐CD8–PerCP‐Cy5.5, and anti‐PD‐L1–PE conjugated antibodies were purchased from BD Biosciences. PD‐1 antibody (αPD‐1, clone: RMP1‐14) and IgG2a isotype control (clone: 2A3) were purchased from BioXcell.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!